Oxacillin sodium salt
(Synonyms: 苯唑西林钠) 目录号 : GC33964A semisynthetic β-lactam antibiotic
Cas No.:1173-88-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Oxacillin is a semisynthetic β-lactam antibiotic.1,2 It is active against clinical isolates of methicillin-susceptible S. aureus and penicillin-susceptible S. pneumoniae, as well as group A, group B, and viridans group streptococci with MIC90 values ranging from 0.06 to 2 ?g/ml in vitro.3 Oxacillin is less effective toward other bacteria with MIC90 values of greater than 16 ?g/ml for S. epidermidis, S. haemolyticus, E. faecalis, E. faecium, methicillin-resistant S. aureus (MRSA), and penicillin-intermediate and -resistant S. pneumoniae. It targets the bacterial cell wall, inhibiting S. pneumoniae penicillin-binding proteins 1a, 1b, 2a, 2b, and 3 in vitro with IC50 values ranging from 0.17 to 1.75 ?M.4,2 Oxacillin inhibits growth of S. aureus in a thigh model of infection in mice (ED50 = 45.19 mg/kg, s.c.).5 Formulations containing oxacillin have been used in the treatment of susceptible bacterial infections.
1.Hawks, G.H.Antibiotic therapy of staphylococcal infectionCan. Med. Assoc. J.93(16)848-853(1965) 2.Williamson, R., Hakenbeck, R., and Tomasz, A.In vivo interaction of β-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniaeAntimicrob. Agents Chemother.18(4)629-637(1980) 3.Milatovic, D., Schmitz, F.J., Verhoef, J., et al.Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolatesAntimicrob. Agents Chemother.47(1)400-404(2003) 4.Balibar, C.J., Shen, X., McGuire, D., et al.cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureusMicrobiology156(Pt 5)1372-1383(2010) 5.Rodriguez, C.A., Agudelo, M., Zuluaga, A.F., et al.In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillinBMC Infect. Dis.10(153)(2010)
Cas No. | 1173-88-2 | SDF | |
别名 | 苯唑西林钠 | ||
Canonical SMILES | [O-]C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C3=C(C)ON=C3C4=CC=CC=C4)=O)N1C2=O)=O.[Na+] | ||
分子式 | C19H18N3NaO5S | 分子量 | 423.42 |
溶解度 | DMF: 20 mg/ml,DMSO: 16 mg/ml,Ethanol: 2 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3617 mL | 11.8086 mL | 23.6172 mL |
5 mM | 0.4723 mL | 2.3617 mL | 4.7234 mL |
10 mM | 0.2362 mL | 1.1809 mL | 2.3617 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。